Immunotherapy for human papillomavirus-associated disease and cervical cancer: review of clinical and translational research
about
Perspectives for therapeutic HPV vaccine developmentCervical Cancer Neoantigen Landscape and Immune Activity is Associated with Human Papillomavirus Master Regulators.Interferon α Induces the Apoptosis of Cervical Cancer HeLa Cells by Activating both the Intrinsic Mitochondrial Pathway and Endoplasmic Reticulum Stress-Induced Pathway.DNA Vaccine Encoding HPV16 Oncogenes E6 and E7 Induces Potent Cell-mediated and Humoral Immunity Which Protects in Tumor Challenge and Drives E7-expressing Skin Graft RejectionGlycyrrhiza uralensis water extract enhances dendritic cell maturation and antitumor efficacy of HPV dendritic cell-based vaccine.Enhancing antitumor immunogenicity of HPV16-E7 DNA vaccine by fusing DNA encoding E7-antigenic peptide to DNA encoding capsid protein L1 of Bovine papillomavirus.Cervical cancer screening in the era of HPV vaccination: A review of shifting paradigms in cytopathology.Paracrine release of IL-2 and anti-CTLA-4 enhances the ability of artificial polymer antigen-presenting cells to expand antigen-specific T cells and inhibit tumor growth in a mouse model.The current state of therapeutic and T cell-based vaccines against human papillomaviruses.Investigational drugs for the treatment of cervical cancer.Cervical cancer: A global health crisis.Current status and future prospects for human papillomavirus vaccines.Targeting Persistent Human Papillomavirus Infection.Viral Interplay with the Host Sumoylation System.Therapeutic vaccines for high-risk HPV-associated diseases.E2/E6 ratio and L1 immunoreactivity as biomarkers to determine HPV16-positive high-grade squamous intraepithelial lesions (CIN2 and 3) and cervical squamous cell carcinoma.The relationship between the PD-1/PD-L1 pathway and DNA mismatch repair in cervical cancer and its clinical significance.Engineered T cells targeting E7 mediate regression of human papillomavirus cancers in a murine model.
P2860
Q28069272-6E55AA52-750C-4583-AB58-498CF125A524Q33806351-2A5BC008-6FB3-4300-94D5-ABE76256D7F7Q37465474-6E530EBB-90CD-469B-8329-8F77AD6398ACQ37626311-904FD2F5-8C4D-4B01-BCDA-7313F66D741CQ37686631-F2CE716F-6704-482D-9E36-7286C969252EQ38635840-429389A8-1051-4487-BBB6-1ACB9D0B9CD4Q38673879-EBC0F13B-A99C-4ED8-8797-84B35A6B5699Q38684217-879B2438-993A-47B2-98E0-A058A0291495Q39033576-58BDAC80-EF25-4704-BB85-917BFCCC51B7Q39168925-2A213FC8-F5E9-43DE-8BC5-0E08FD04A9F5Q39278591-14F5A8E6-023D-4E5C-81A1-A747DC74688BQ40056541-D458B162-E344-4B85-A657-67196D7A9CB6Q40078375-3371F9DB-A0D3-46F6-8118-9C2DB2101A71Q40332996-EE9A8ECE-E50C-4662-AA51-6ED1EF88D364Q47255618-37A7D1C1-9F5B-42E9-831C-F134CB4B76C4Q48107178-CE359B4F-3114-42F9-8A91-8D0DE65405B4Q49623227-3AAAFB91-59A9-4041-AEC3-8ECC483F4F25Q55086081-C3FC0335-4FD9-4D19-9129-CF2AC64F8AFF
P2860
Immunotherapy for human papillomavirus-associated disease and cervical cancer: review of clinical and translational research
description
2016 nî lūn-bûn
@nan
2016 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
name
Immunotherapy for human papill ...... cal and translational research
@ast
Immunotherapy for human papill ...... cal and translational research
@en
Immunotherapy for human papill ...... cal and translational research
@nl
type
label
Immunotherapy for human papill ...... cal and translational research
@ast
Immunotherapy for human papill ...... cal and translational research
@en
Immunotherapy for human papill ...... cal and translational research
@nl
prefLabel
Immunotherapy for human papill ...... cal and translational research
@ast
Immunotherapy for human papill ...... cal and translational research
@en
Immunotherapy for human papill ...... cal and translational research
@nl
P2093
P2860
P50
P921
P3181
P356
P1476
Immunotherapy for human papill ...... cal and translational research
@en
P2093
Andrew Yang
Chien Fu Hung
Sung Jong Lee
P2860
P3181
P356
10.3802/JGO.2016.27.E51
P407
P5008
P577
2016-09-01T00:00:00Z